Results 1 to 10 of about 9,263,948 (394)

A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin [PDF]

open access: yesClinical Case Reports, 2020
Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement ...
Federico Meconi   +9 more
doaj   +2 more sources

Hodgkin Disease—An Ever-Evolving Therapy [PDF]

open access: yesRambam Maimonides Medical Journal, 2014
Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity.
Eldad J. Dann
doaj   +2 more sources

Pseudoautosomal Linkage of Hodgkin Disease [PDF]

open access: bronzeAmerican Journal of Human Genetics, 1999
Heritable factors appear to account for much of the risk for Hodgkin disease (HD). There is evidence for an HLA-linked gene, but other predisposing loci remain unaccounted for.
Marshall S. Horwitz, Peter H. Wiernik
openalex   +2 more sources

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial [PDF]

open access: bronzeBlood, 2003
Lymphocyte-predominant Hodgkin disease (LPHD) is a unique clinical entity characterized by indolent nodal disease that tends to relapse after standard radiotherapy or chemotherapy.
Bradley C. Ekstrand   +8 more
openalex   +2 more sources

Hodgkin disease survivors at increased risk for problems in psychosocial adaptation [PDF]

open access: bronzeCancer, 1992
Alice B. Kornblifh   +13 more
openalex   +2 more sources

Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients’ Outcome in Classical Hodgkin Lymphoma [PDF]

open access: yesMiddle East Journal of Cancer, 2022
Background: Tumor microenvironment, specifically tumor-associated macrophages, plays an important role in tumor initiation and progression. CD163 has been recognized as a valuable specific macrophage marker.
Rania Makboul   +6 more
doaj   +1 more source

Classical Hodgkin lymphoma following follicular lymphoma: a case report [PDF]

open access: yesJournal of Yeungnam Medical Science, 2023
The simultaneous, composite, or sequential occurrence of follicular lymphoma (FL) and classical Hodgkin lymphoma (HL), both of which originate from germinal center B-cell, is rare.
Bomi Kim
doaj   +1 more source

Immune Thrombocytopenic Purpura Evolving into Hodgkin’s Disease in a Young Boy [PDF]

open access: yesBengal Physician Journal, 2022
Immune thrombocytopenic purpura (ITP) is a common bleeding disorder, and it may be primary (no potential etiologies found) or secondary (underlying associated conditions).
Karimulla Mondal   +4 more
doaj   +1 more source

Digital Clubbing and Hodgkin Disease in Children: A Case Report and Review of Literature

open access: yesJournal of Pediatrics Review, 2021
Introduction: Digital clubbing (hypertrophic osteoarthropathy) as the initial presentation of lymphoma is rarely reported, particularly in children. In this study, we report a patient with intrathoracic Hodgkin Disease (HD) and digital clubbing as the ...
Hossein Karami   +6 more
doaj   +1 more source

Tuberculous Adenitis with Concurrent Hodgkin Lymphoma: A Case Report

open access: yesOman Medical Journal, 2020
The concomitant occurrence of tuberculous adenitis and Hodgkin lymphoma is rare, posing a diagnostic dilemma since both have similar symptoms, such as lymphadenopathy, weight loss, fever, and night sweats.
Fahmi Yousef Khan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy